
CAR-T Clinical Study Project Approved by China National Center for Biotechnology Development
The single-center clinical trial of CAR-T therapy for metastatic castration-resistant prostate cancer, led by Oncology Director Cui Jiuwei, received official approval. It is the hospital's first project approved under the new State Council regulations, signifying enhanced capabilities in solid tumor cell therapy research.
The First Bethune Hospital of Jilin University



